Libenar Side effects

• Side effects of Libenar in details
• Libenar contraindications
• Libenar reviews

What are the possible side effects of Libenar?

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using Libenar flush and call your doctor at once if you have any of these side effects while using the flush:

• severe irritation;

• swelling;

• warmth;

• redness;

• oozing; or

• pain.

Common side effects may include:

• cold feeling or mild burning; or

• mild irritation around the catheter.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Side effects of Libenar in details

Post-Marketing Adverse Reactions

The following adverse reactions have been identified during postapproval use of Libenar Injection, USP. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

The following adverse reactions have been reported in the post-marketing experience during use of 0.9% Libenar Injection, USP and include the following:

hypersensitivity/infusion reactions, including hypotension, pyrexia, tremor, chills, urticaria, rash, and pruritus.

Also reported are infusion site reactions, such as infusion site erythema, injection site streaking, burning sensation, and infusion site urticaria.

The following adverse reactions have not been reported with 0.9% Libenar Injection, USP but may occur: hypernatremia, hyperchloremic metabolic acidosis, and hyponatremia, which may be symptomatic.

Hyponatremia has been reported for 0.45% Libenar Injection, USP.

The following adverse reactions have not been reported with 0.45% Libenar Injection, USP but may occur: hyperchloremic metabolic acidosis, hypersensitivity/infusion reactions (including hypotension, pyrexia, tremor, chills, urticaria, rash, and pruritus), and infusion site reactions (such as infusion site erythema, injection site streaking, burning sensation, infusion site urticaria).

If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

What is the most important information I should know about Libenar?

• Misuse of Libenar may be harmful. Be sure you know how to properly use Libenar. Talk with your doctor or pharmacist if you have any questions.
• In a hot environment it is necessary to have adequate hydration and balanced electrolyte replacement.
• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.
• Lab tests, including electrolyte levels, may be performed while you use Libenar. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.
• Libenar should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.
• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Libenar while you are pregnant. It is not known if Libenar is found in breast milk. If you are or will be breast-feeding while you use Libenar, check with your doctor. Discuss any possible risks to your baby.

Libenar contraindications

Due to potential toxicity of benzyl alcohol in newborns, Bacteriostatic Libenar Injection, USP, 0.9% containing benzyl alcohol must not be used in this patient population.

Bacteriostatic Libenar Injection, USP, 0.9% should not be used for fluid or Libenar replacement.

References

1. DailyMed. "AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
2. DTP/NCI. "sodium chloride: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
3. European Chemicals Agency - ECHA. "Sodium chloride: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Libenar are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Libenar. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 19 here

Information checked by Dr. Sachin Kumar, MD Pharmacology